{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:21:54Z","timestamp":1774005714293,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.nmd.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T18:48:56Z","timestamp":1676141336000},"page":"288-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1740-4522","authenticated-orcid":false,"given":"Valentina","family":"Damato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorio","family":"Spagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Monte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Scandiffio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Zampetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Falso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fattorossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.02.005_bib0001","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1038\/s41467-020-19238-2","article-title":"Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2023.02.005_bib0002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.nmd.2023.02.005_bib0003","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.nmd.2023.02.005_bib0004","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1007\/s00415-022-11142-7","article-title":"Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study","volume":"269","author":"Giannoccaro","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.02.005_bib0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/annrheumdis-2021-222045","article-title":"Efficacy of COVID-19 vaccines in patients taking immunosuppressants","volume":"81","author":"Shen","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nmd.2023.02.005_bib0006","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1007\/s00415-022-11003-3","article-title":"Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis","volume":"269","author":"Mariottini","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.02.005_bib0007","article-title":"Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD","volume":"58","author":"Dinoto","year":"2021","journal-title":"Mult Scler Relat Dis"},{"key":"10.1016\/j.nmd.2023.02.005_bib0008","article-title":"SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: gender-specific results from a longitudinal observational study","volume":"22","author":"Frahm","year":"2022","journal-title":"Lancet Regional Heal - Europe"},{"key":"10.1016\/j.nmd.2023.02.005_bib0009","first-page":"1112","article-title":"COVID-19 Vaccination in Patients with Myasthenia Gravis: a Single-Center Case Series","volume":"9","author":"Ruan","year":"2021","journal-title":"Nato Adv Sci Inst Se"},{"key":"10.1016\/j.nmd.2023.02.005_bib0010","first-page":"1","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","author":"Apostolidis","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2023.02.005_bib0011","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1212\/WNL.0000000000013108","article-title":"Humoral- and T-Cell\u2013Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies","volume":"98","author":"Tortorella","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.02.005_bib0012","article-title":"Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis","volume":"9","author":"Reyes-Leiva","year":"2022","journal-title":"Neurology Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.nmd.2023.02.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-329284","article-title":"Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis","author":"Damato","year":"2022","journal-title":"J Neurology Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2023.02.005_bib0014","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/cells9061532","article-title":"Cytokine Profile in Striated Muscle Laminopathies: new Promising Biomarkers for Disease Prediction","volume":"9","author":"Cappelletti","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.nmd.2023.02.005_bib0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.42060","article-title":"B cell numbers predict humoral and cellular response upon SARS\u2013CoV-2 vaccination among patients treated with rituximab","volume":"74","author":"Stefanski","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.nmd.2023.02.005_bib0016","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2023.02.005_bib0017","article-title":"The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic","volume":"43","author":"Baker","year":"2020","journal-title":"Mult Scler Relat Dis"},{"key":"10.1016\/j.nmd.2023.02.005_bib0018","doi-asserted-by":"crossref","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.nmd.2023.02.005_bib0019","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"issue":"20","key":"10.1016\/j.nmd.2023.02.005_bib0020","article-title":"NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals","volume":"28","author":"Cuapio","year":"2022","journal-title":"Mol Med"},{"key":"10.1016\/j.nmd.2023.02.005_bib0021","doi-asserted-by":"crossref","first-page":"eabd6832","DOI":"10.1126\/sciimmunol.abd6832","article-title":"Natural killer cell immunotypes related to COVID-19 disease severity","volume":"5","author":"Maucourant","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.nmd.2023.02.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.nmd.2023.02.005_bib0023","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:07Z","timestamp":1760775187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0960896623000251"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.02.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}